Drug profile · INN
aflibercept-abzv
ENZEEVU
aflibercept-abzv (ENZEEVU) is a placenta growth factor inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — aflibercept-abzv
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
aflibercept-abzv (ENZEEVU) is a placenta growth factor inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Placenta growth factor inhibitor
Primary target: Placenta growth factor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is aflibercept-abzv?
aflibercept-abzv (ENZEEVU) is a placenta growth factor inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for aflibercept-abzv?
ENZEEVU is a marketed brand name for aflibercept-abzv. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aflibercept-abzv?
aflibercept-abzv has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.